Jun 08, 2017 12:00 pm UTC| Business
-- Factor IX oral presentation Factor VIIa poster presentation -- -- Presentations to summarize the pharmacokinetics and activity of daily subcutaneous dosing in preclinical hemophilia models -- SOUTH SAN FRANCISCO,...
InvisibleShield Announces the Luxe Protective Bumper Case for the Apple Watch Series 1 and Series 2
Jun 08, 2017 12:00 pm UTC| Business
SALT LAKE CITY, June 08, 2017 -- InvisibleShield®, the leading global brand and innovator in screen protection, today announced the InvisibleShield Luxe™ Protective Bumper Case for the Apple Watch® 38mm and 42mm Series...
Echoing Green Announces ‘the Talent to Change the World’ with Its 2017 Fellowship Awards
Jun 08, 2017 12:00 pm UTC| Business
NEW YORK, June 08, 2017 -- Turning chicken feathers into sustainable home insulation… Bringing racial equity to cannabis by creating pathways for underground distributors to enter the legal cannabis industry… ...
Oklahoma Sears Hometown Stores to See New Refreshed Retail Appliance Strategy at Three Locations
Jun 08, 2017 12:00 pm UTC| Business
WEATHERFORD, Okla., June 08, 2017 -- Evolving to meet changing consumer needs and to embrace its nationwide branding as “America’s Appliance Experts®,” the refresh of three Sears Hometown and Outlet Stores in Oklahoma...
Doha Marriott Celebrates Guest’s 20-Year Rewards Anniversary
Jun 08, 2017 11:54 am UTC| Business
DOHA, Qatar, June 08, 2017 -- The Doha Marriott recently honored long-time guest of the hotel Mr. Tom Scheidel with a celebration of his 20-year Marriott Rewards anniversary, on April 26th, 2017. Mr. Scheidel has been...
Jun 08, 2017 11:30 am UTC| Business
TORONTO, June 08, 2017 -- dynaCERT Inc. (TSX VENTURE:DYA)(OTCQB:DYFSF) ("dynaCERT" or the "Company") is pleased to announce that Michael Christodoulou, the former President of Cummins Eastern Canada LP and Cummins...
Jun 08, 2017 11:30 am UTC| Business
- Society of Nuclear Medicine and Molecular Imaging to be held June 10 – 14, 2017 in Denver, Colorado - Actinium to conduct webinar to provide an update on its Pivotal Phase 3 drug candidate, Iomab-B, on Monday June 12,...